 | Up a level |
Garrelfs, Sander F.; Frishberg, Yaacov; Hulton, Sally A.; Koren, Michael J.; O’Riordan, William D.; Cochat, Pierre; Deschênes, Georges; Shasha-Lavsky, Hadas; Saland, Jeffrey M.; van’t Hoff, William G.; Fuster, Daniel G.; Magen, Daniella; Moochhala, Shabbir H.; Schalk, Gesa; Simkova, Eva; Groothoff, Jaap W.; Sas, David J.; Meliambro, Kristin A.; Lu, Jiandong; Sweetser, Marianne T.; ... (2021). Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. New England journal of medicine NEJM, 384(13), pp. 1216-1226. Massachusetts Medical Society MMS 10.1056/NEJMoa2021712
